| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |